Related Experiment Video

Updated: Aug 19, 2026

Quantification of Cytokine-Induced Cell Death in Human Colonic Organoids Using Live Fluorescence Microscopy
10:03

Quantification of Cytokine-Induced Cell Death in Human Colonic Organoids Using Live Fluorescence Microscopy

Published on: August 2, 2024

Recent advances in understanding the cell death pathways activated by anticancer therapy

Ryungsa Kim1

  • 1International Radiation Information Center, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan. rkim@hiroshima-u.ac.jp

Cancer
|March 3, 2005
PubMed

Insights

Anticancer drugs induce cell death through apoptosis, primarily via the mitochondrial pathway involving Bcl-2 proteins. Understanding these mechanisms can reveal new targets to enhance chemotherapy effectiveness.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Pharmacology

Background:

  • Apoptosis is crucial for anticancer drug cytotoxicity.
  • Two main apoptosis pathways exist: death receptor-dependent (extrinsic) and intrinsic (mitochondrial).
  • Mitochondria are central to intrinsic apoptosis, interacting with other organelles.

Purpose of the Study:

  • Review recent advances in anticancer agent-induced cell death mechanisms.
  • Discuss potential molecular targets to improve chemotherapy.
  • Highlight the role of mitochondria and Bcl-2 family proteins.

Main Methods:

  • Literature review of apoptosis and anticancer drug mechanisms.
  • Analysis of mitochondrial and endoplasmic reticulum interactions in cell death.
  • Examination of Bcl-2 family protein regulation of mitochondrial pathways.

Main Results:

  • Mitochondria mediate intrinsic apoptosis via Bcl-2 proteins, controlling cytochrome c and caspase activation.
  • Cross-talk between apoptosis and autophagy pathways can occur.
  • Anticancer agents trigger diverse cell death mechanisms.

Conclusions:

  • Mitochondrial apoptosis pathway is a key target for anticancer drug action.
  • Targeting Bcl-2 family proteins and related pathways may enhance chemotherapy.
  • Further research into cell death mechanisms can lead to improved cancer treatments.

More Related Videos

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...